USP22 and colon adenocarcinoma: By contrast, the deubiquitinating enzyme USP22 promotes PD-L1 stabilization in colon cancer (COAD), while EZH2 inhibits USP22 transcription via H3K27me3, leading to PD-L1 degradation [165].